These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35324372)

  • 21. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi.
    Meher R; Wadhwa V; Kumar V; Shisha Phanbuh D; Sharma R; Singh I; Rathore PK; Goel R; Arora R; Garg S; Kumar S; Kumar J; Agarwal M; Singh M; Khurana N; Sagar T; Manchanda V; Saxena S
    Am J Otolaryngol; 2022; 43(1):103220. PubMed ID: 34547717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.
    Ravindra K; Ahlawat A
    Int J Infect Dis; 2021 Nov; 112():278-280. PubMed ID: 34592439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.
    Jawanda MK; Narula R; Gupta S; Sharma V; Gupta P; Kaur M
    Acta Medica (Hradec Kralove); 2021; 64(4):227-231. PubMed ID: 35285446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finegoldia magna and Mucorales molds co-infection in a severe case of SARS-CoV-2 disease.
    Hristova R; Vlahova A; Christova M; Stamatov K; Stanimirov P
    J Infect Dev Ctries; 2023 Sep; 17(9):1231-1236. PubMed ID: 37824356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico.
    Guzmán-Castro S; Chora-Hernandez LD; Trujillo-Alonso G; Calvo-Villalobos I; Sanchez-Rangel A; Ferrer-Alpuin E; Ruiz-Jimenez M; Corzo-Leon DE
    Mycoses; 2022 Jan; 65(1):65-70. PubMed ID: 34674319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
    Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
    Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review.
    Sarfraz Z; Sarfraz A; Jaiswal V; Poudel S; Bano S; Hanif M; Singh Shrestha P; Sarfraz M; Michel G; Cherrez-Ojeda I
    J Prim Care Community Health; 2022; 13():21501319221099476. PubMed ID: 35587142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.
    Meshram HS; Kute VB; Chauhan S; Dave R; Patel H; Banerjee S; Desai S; Kumar D; Navadiya V; Mishra V
    Int Urol Nephrol; 2022 Jul; 54(7):1693-1703. PubMed ID: 34792722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coincidence or reality behind Mucormycosis, diabetes mellitus and Covid-19 association: A systematic review.
    Sengupta I; Nayak T
    J Mycol Med; 2022 Aug; 32(3):101257. PubMed ID: 35219907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.
    Dallalzadeh LO; Ozzello DJ; Liu CY; Kikkawa DO; Korn BS
    Orbit; 2022 Oct; 41(5):616-619. PubMed ID: 33752571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The second wave of COVID-19 results in outbreak of mucormycosis: diabetes and immunological perspective.
    Ahirwar AK; Kaim K; Ahirwar P; Kumawat R
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):353-355. PubMed ID: 34908254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
    Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
    Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic.
    Ghazi BK; Rackimuthu S; Wara UU; Mohan A; Khawaja UA; Ahmad S; Ahmad S; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY
    Am J Trop Med Hyg; 2021 Aug; 105(5):1144-1147. PubMed ID: 34460426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
    Afzal S; Nasir M
    J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucormycosis: An opportunistic pathogen during COVID-19.
    Mahalaxmi I; Jayaramayya K; Venkatesan D; Subramaniam MD; Renu K; Vijayakumar P; Narayanasamy A; Gopalakrishnan AV; Kumar NS; Sivaprakash P; Sambasiva Rao KRS; Vellingiri B
    Environ Res; 2021 Oct; 201():111643. PubMed ID: 34237335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
    Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
    Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.